Publicacións nas que colabora con María Teresa Otero Barrós (7)

2024

  1. Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol

    Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1

  2. Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study

    The Lancet Infectious Diseases, Vol. 24, Núm. 8, pp. 817-828

  3. Short- and mid-term morbidity and primary-care burden due to infant respiratory syncytial virus infection: A Spanish 6-year population-based longitudinal study

    Pediatric Allergy and Immunology, Vol. 35, Núm. 5

2023

  1. Administración de nirsevimab: estrategia de campaña versus estrategia de calendario

    XLI Reunión Anual de la Sociedad Española de Epidemiología (SEE) y XVIII Congresso da Associação Portuguesa de Epidemiología (APE)

  2. COVID-19 vaccine effectiveness against Omicron variant in pediatric galician population

    XLI Reunión Anual de la Sociedad Española de Epidemiología (SEE) y XVIII Congresso da Associação Portuguesa de Epidemiología (APE)

  3. COVID-19 vaccine effectiveness in children by age groups. A population-based study in Galicia, Spain

    Pediatric Allergy and Immunology, Vol. 34, Núm. 10

2022

  1. Effectiveness of COVID-19 vaccine booster in the general population and in subjects with comorbidities. A population-based study in Spain

    Environmental Research, Vol. 215